Recce Pharmaceuticals Statistics

Total Valuation

ASX:RCE has a market cap or net worth of AUD 133.02 million. The enterprise value is 133.47 million.

Market Cap	133.02M
Enterprise Value	133.47M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:RCE has 289.18 million shares outstanding. The number of shares has increased by 36.61% in one year.

Current Share Class	289.18M
Shares Outstanding	289.18M
Shares Change (YoY)	+36.61%
Shares Change (QoQ)	+18.03%
Owned by Insiders (%)	24.80%
Owned by Institutions (%)	14.84%
Float	201.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	136.50
PB Ratio	-7.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.41
EV / Sales	136.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.79

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-21.38

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-581.01%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	309.84%
Weighted Average Cost of Capital (WACC)	6.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.31
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.32% in the last 52 weeks. The beta is 0.20, so ASX:RCE's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+24.32%
50-Day Moving Average	0.61
200-Day Moving Average	0.46
Relative Strength Index (RSI)	28.36
Average Volume (20 Days)	72,303

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RCE had revenue of AUD 974,559 and -30.25 million in losses. Loss per share was -0.11.

Revenue	974,559
Gross Profit	-11.18M
Operating Income	-29.04M
Pretax Income	-30.25M
Net Income	-30.25M
EBITDA	-28.99M
EBIT	-29.04M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 365,256 in cash and 806,344 in debt, giving a net cash position of -441,088 or -0.00 per share.

Cash & Cash Equivalents	365,256
Total Debt	806,344
Net Cash	-441,088
Net Cash Per Share	-0.00
Equity (Book Value)	-18.62M
Book Value Per Share	-0.06
Working Capital	-10.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.01 million and capital expenditures -35,390, giving a free cash flow of -23.04 million.

Operating Cash Flow	-23.01M
Capital Expenditures	-35,390
Free Cash Flow	-23.04M
FCF Per Share	-0.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,980.30%
Pretax Margin	-3,104.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:RCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.61%
Shareholder Yield	-36.61%
Earnings Yield	-22.74%
FCF Yield	-17.32%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RCE has an Altman Z-Score of -123.64 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-123.64
Piotroski F-Score	1